Filippo Fioretti and Ombline Ancelin discuss the controversial Italian case finding a collusive strategy in the off label use of a medicine and the damages action it triggered.
Filippo Fioretti and Ombline Ancelin discuss the controversial Italian case finding a collusive strategy in the off label use of a medicine and the damages action it triggered.